Access to guideline-recommended supportive oncology medications in Medicare Part D.
328 Background: Supportive care medications are central to oncologic outcomes, yet unlike antineoplastic agents protected under Medicare Part D's six protected-class rules, supportive care agents remain subject to plan-level formulary and utilization management policies without equivalent federal protection. Th...